Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Sportradar Group AG (SRAD – Research Report) today. The company’s shares closed last Friday at $10.13.
According to TipRanks, Hewitt is a 3-star analyst with an average return of 2.2% and a 45.42% success rate. Hewitt covers the Healthcare sector, focusing on stocks such as Codexis, Avid Bioservices, and Champions Oncology.
Currently, the analyst consensus on Sportradar Group AG is a Moderate Buy with an average price target of $14.00.
See the top stocks recommended by analysts >>
SRAD market cap is currently $3.01B and has a P/E ratio of -141.28.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Sportradar Group AG (SRAD) Company Description:
Sportradar Group AG is a technology platform enabling next-generation engagement in sports, and a provider of B2B solutions to the global sports betting industry. It generates revenue through two primary sources: subscription-based revenue and revenue sharing.
Read More on SRAD:
- SRAD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Sportradar To Release Fourth Quarter And Full Year 2023 Financial Results On March 20, 2024
- Sportradar Announces Automated Odds Recalculation Tool, Alpha Odds, Boosted Client Profits by Average of 10% in 2023
- Bet On It: Barstool eyes marketing partnership with DraftKings after lock-up
- Sportradar Announces Additional Strategic Actions to Streamline Organizational Structure and Drive Growth and Innovation
